Can a team of doctors improve lung cancer care for seniors?

NCT ID NCT07509333

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a team of specialists—including surgeons, oncologists, and geriatricians—can create better treatment plans for elderly lung cancer patients. 2,000 people aged 60-90 will receive personalized care based on their overall health and cancer type. The goal is to see if this team approach improves survival and quality of life compared to standard care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Multidisciplinary team (MDT) decision-making model
What this could lead to
If successful, this could establish a standardized team approach to personalize treatment for elderly lung cancer patients, potentially improving survival and reducing side effects.
What could go wrong
This is a single-center study with historical controls, not a randomized trial, so results may be less reliable. The model may not work for all patients or be easy to implement elsewhere.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARCINOMA, NON-SMALL-CELL LUNG are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • West China Hospital, Sichuan University

    RECRUITING

    Chengdu, Sichuan, 610041, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.